Filing Details
- Accession Number:
- 0001415889-25-019067
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-02 16:33:27
- Reporting Period:
- 2025-06-30
- Filing Date:
- 2025-07-02
- Accepted Time:
- 2025-07-02 16:33:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1420987 | A James Schoeneck | C/O Fibrogen, Inc. 350 Bay Street, Suite 100, #6009 San Francisco CA 94133 | No | No | No | No |
Transaction Summary
Purchased: | 23,567 shares | Avg. Price: $5.07 | Total Value: $119,484.69 |
Number of Shares After Transactions: | 39,666 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-06-30 | 23,567 | $5.07 | 39,666 | No | 4 | P | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Trust |
Footnotes
- Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $4.935 to $5.25. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- Reflects a 1-for-25 reverse stock split effective on June 16, 2025.